Summit Securities Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-116
Closed -$3K 638
2015
Q1
$3K Buy
+116
New +$3K ﹤0.01% 304
2014
Q4
Hold
0
678
2014
Q3
Hold
0
736